In their research, scientists have identified a change in gene expression in the placenta of pregnant women with cancer. The ...

Q1 2025 Earnings Call Transcript May 2, 2025 Operator: Thank you for standing by. Hello and welcome to the Summit ...

Q1 2025 Earnings Call Transcript May 2, 2025 Fulgent Genetics, Inc. misses on earnings expectations. Reported EPS is $-0.37396 EPS, expectations were $-0.19. Melanie Solomon: Greetings and welcome to ...

Most skin cancers are treatable, mainly if they're found early. Regular skin checks are an important part of your health ...

Northwestern Medicine scientists have identified a key driver of chemotherapy resistance in advanced ovarian cancer, ...

The immune system is comprised of two separate active arms of immunity to provide robust protection against disease. The two separate systems of immunity i | Immunology ...

Researchers at Karolinska Institutet have uncovered a unique ability of a special subtype of natural killer cells in the ...

Amber Kelleher-Andrews, a renowned matchmaker, has passed away at 56 after battling stage 4 ovarian cancer. Diagnosed in 2017, the cancer briefly went into remission before returning aggressively.

Researchers have uncovered a unique ability of a special subtype of natural killer cells in the immune system, called adaptive NK cells, to remember ovarian tumors and effectively attack them. The ...

INX-315, a CDK2 inhibitor, targets CCNE1-amplified platinum-resistant ovarian cancer, addressing a significant unmet need in this patient population. The FDA's fast track designation facilitates ...

DB-1305/BNT325 was generally well tolerated and exhibited “very encouraging and durable antitumor activity in ovarian cancer patients,” said Maria Rubinstein, MD.